Nasdaq
NCEL
NewcelX Ltd.
- Health Care
- Switzerland
- Listed 2021
- 1 day
- −6.2%
- 1 month
- −16.7%
- 1 year
- −82.3%
$3.34 · Mkt cap $18.0M · P/E 1.55
At the 6 Aug 2026 close
Nasdaq
NewcelX Ltd.
$3.34 · Mkt cap $18.0M · P/E 1.55
At the 6 Aug 2026 close
NewcelX Ltd. trades under the ticker NCEL on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). It has been listed since 2021. Its market capitalisation is $18.0M. The last closing price was $3.34, on 6 Aug 2026. It trades at 1.55 times its last reported annual diluted earnings per share. Over the past year the share price is −82.3%, and −16.7% over the past month. Returns are price returns and exclude dividends.
This page exists because NCEL is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.